Guardant Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	563.95	449.54	373.65	286.73	214.38	90.64	49.84	25.25
Revenue Growth (YoY)	25.45%	20.31%	30.32%	33.75%	136.52%	81.85%	97.40%	-
Cost of Revenue	227.05	156.33	122.91	92.54	70.72	43.21	31.62	22.12
Gross Profit	336.9	293.21	250.74	194.2	143.66	47.43	18.22	3.13
Selling, General & Admin	451.03	463.78	398.52	299.28	139.73	89.66	69.27	36.11
Research & Development	367.19	373.81	263.22	149.86	86.29	50.71	25.56	10.86
Other Operating Expenses	83.4	0	0	0	0	0	0	0
Operating Expenses	901.62	837.59	661.74	449.15	226.03	140.37	94.84	46.97
Operating Income	-564.73	-544.38	-411	-254.95	-82.37	-92.94	-76.61	-43.85
Interest Expense / Income	2.58	2.58	2.58	4.77	1.18	1.25	2.7	3.02
Other Expense / Income	-88.54	106.49	-8.21	-6.31	-6.03	-9.17	3.9	-0.73
Pretax Income	-478.76	-653.45	-405.37	-253.4	-77.52	-85.03	-83.21	-46.13
Income Tax	0.69	1.14	0.3	0.38	-1.87	0.04	0.01	0.01
Net Income	-479.45	-654.59	-405.67	-253.78	-75.65	-85.06	-83.22	-46.14
Preferred Dividends	0	0	0	0	0	0	5.77	0
Net Income Common	-479.45	-654.59	-405.67	-253.78	-75.65	-85.06	-89	-46.14
Shares Outstanding (Basic)	112	102	101	98	91	30	13	13
Shares Outstanding (Diluted)	112	102	101	98	91	30	13	13
Shares Change	9.60%	0.85%	3.91%	7.62%	197.99%	141.64%	-3.61%	-
EPS (Basic)	-4.28	-6.41	-4.00	-2.60	-0.84	-2.80	-7.07	-3.53
EPS (Diluted)	-4.28	-6.41	-4.00	-2.60	-0.84	-2.80	-7.07	-3.53
Free Cash Flow	-345.46	-386.92	-284.05	-157.99	-68.35	-92.39	-78.92	-38.48
Free Cash Flow Per Share	-3.08	-3.79	-2.80	-1.62	-0.75	-3.04	-6.27	-2.95
Gross Margin	59.74%	65.23%	67.11%	67.73%	67.01%	52.33%	36.56%	12.38%
Operating Margin	-100.14%	-121.10%	-110.00%	-88.92%	-38.42%	-102.54%	-153.71%	-173.66%
Profit Margin	-85.02%	-145.61%	-108.57%	-88.51%	-35.29%	-93.85%	-178.55%	-182.74%
Free Cash Flow Margin	-61.26%	-86.07%	-76.02%	-55.10%	-31.88%	-101.93%	-158.33%	-152.39%
EBITDA	-433.31	-614.91	-380.52	-227.01	-60.52	-76.64	-75.31	-39.42
EBITDA Margin	-76.83%	-136.79%	-101.84%	-79.17%	-28.23%	-84.55%	-151.09%	-156.13%
Depreciation & Amortization	42.88	35.96	22.27	21.63	15.82	7.14	5.21	3.69
EBIT	-476.19	-650.87	-402.79	-248.64	-76.34	-83.77	-80.51	-43.12
EBIT Margin	-84.44%	-144.79%	-107.80%	-86.72%	-35.61%	-92.43%	-161.53%	-170.76%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).